These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8863819)

  • 1. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
    Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of 5-HT-moduline as a drug target for affective disorders.
    Fillion G
    Curr Opin Investig Drugs; 2000 Sep; 1(1):104-9. PubMed ID: 11249585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas.
    Bonnin A; Grimaldi B; Fillion MP; Fillion G
    Brain Res; 1999 Apr; 825(1-2):152-60. PubMed ID: 10216182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific interaction of 5-HT-moduline with human 5-HT1b as well as 5-HT1d receptors expressed in transfected cultured cells.
    Rousselle JC; Plantefol M; Fillion MP; Massot O; Pauwels PJ; Fillion G
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):279-86. PubMed ID: 9774213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype.
    Massot O; Rousselle JC; Grimaldi B; Cloëz-Tayarani I; Fillion MP; Plantefol M; Bonnin A; Prudhomme N; Fillion G
    Ann N Y Acad Sci; 1998 Dec; 861():174-82. PubMed ID: 9928255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [5HT-moduline an new peptide specifically interactive with the serotonergic system: physiopathologic implications].
    Fillion G
    Ann Pharm Fr; 1998; 56(4):145-7. PubMed ID: 9770005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors.
    Cloëz-Tayarani I; Cardona A; Rousselle JC; Massot O; Edelman L; Fillion G
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9899-904. PubMed ID: 9275223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice.
    Sarhan H; Grimaldi B; Hen R; Fillion G
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):12-8. PubMed ID: 10651141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis.
    Bentué-Ferrer D; Reymann JM; Rousselle JC; Massot O; Bourin M; Allain H; Fillion G
    Eur J Pharmacol; 1998 Oct; 358(2):129-37. PubMed ID: 9808261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
    Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role and therapeutic potential of 5-HT-moduline in psychiatry.
    Moret C; Grimaldi B; Massot O; Fillion G
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):137-46. PubMed ID: 12728412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.
    Davidson C; Ho M; Price GW; Jones BJ; Stamford JA
    Br J Pharmacol; 1997 Jun; 121(4):737-42. PubMed ID: 9208142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.
    Brys R; Josson K; Castelli MP; Jurzak M; Lijnen P; Gommeren W; Leysen JE
    Mol Pharmacol; 2000 Jun; 57(6):1132-41. PubMed ID: 10825383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions.
    Marcoli M; Maura G; Munari C; Ruelle A; Raiteri M
    Br J Pharmacol; 1999 Feb; 126(3):607-12. PubMed ID: 10188970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze.
    Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
    Behav Brain Res; 2005 Mar; 158(2):339-48. PubMed ID: 15698901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.